Pfizer, Astellas prostate cancer drug succeeds key trial

(Reuters) - Pfizer Inc and Japan's Astellas Pharma Inc said on Thursday their prostate cancer drug met the main goal of a trial testing it for a more common form of the disease.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news